As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
No linked publications found in PubMed
Inclusion Criteria: * Age ≥ 12 years * AD according to the UK Working Party's Diagnostic Criteria (28) * Moderate to severe AD as defined by * objective SCORAD \> 20 or IGA ≥ 3 (moderate) or * currently on systemic antiinflammatory therapy for AD or * previous systemic antiinflammatory therapy for AD within past 24 months Exclusion Criteria: * refusal to sign the informed consent form